Israeli team grows heart cells from embryonic cells:
This article was originally published in Clinica
Scientists from the Technion-Israel Institute of Technology, Haifa, say they have become the first to successfully grow the precursors of heart cells from human embryonic stem cells. Embryonic stem cells can proliferate far more than stem cells derived from adult tissues and can, therefore, produce the many million of cells needed to repair organs, say the researchers, whose findings appear in the Journal of Clinical Investigation (August).
You may also be interested in...
Office of New Drugs Director Peter Stein said in an interview that a large amount of coronavirus-related work is arriving at the FDA, but so far staff are keeping up.
Akero’s FGF21 analog yields 63%-72% relative hepatic fat reduction in Phase IIa study; the company awaits biopsy data hoping to see a fibrotic benefit. Also, Genfit says COVID-19 pandemic should not significantly delay its Phase III NASH readout.
US Vice President Mike Pence and Medicare administrator Seema Verma want academic and university hospital laboratories to send their de-identified COVID-19 test data results, daily, to the Department of Health and Human Services. Commercial and private labs are exempt from the request, as they already share their coronavirus test results with the government.